Загрузка...
Modulating Th2 Cell Immunity for the Treatment of Asthma
It is estimated that more than 339 million people worldwide suffer from asthma. The leading cause of asthma development is the breakdown of immune tolerance to inhaled allergens, prompting the immune system's aberrant activation. During the early phase, also known as the sensitization phase, al...
Сохранить в:
| Опубликовано в: : | Front Immunol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902894/ https://ncbi.nlm.nih.gov/pubmed/33643321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.637948 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|